Adams Street Partners LLC Crispr Therapeutics Ag Transaction History

Adams Street Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$100.84 - $161.89 $4.19 Million - $6.73 Million	-41,552 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$110.72 - $210.04 $4.6 Million - $8.73 Million	41,552 New	41,552 $5.06 Million
Q4 2020 Feb 11, 2021	SELL	$79.67 - $173.23 $1.77 Million - $3.84 Million	-22,163 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$78.5 - $100.64 $1.74 Million - $2.23 Million	22,163 New	22,163 $1.85 Million
Q4 2017 Feb 12, 2018	SELL	$16.95 - $23.48 $966,624 - $1.34 Million	-57,028 Closed	0 $0

Q3 2017 Nov 13, 2017	BUY	$16.75 - $20.66 $955,219 - $1.18 Million	57,028	57,028 $1.02 Million

550

56.3M

2.91M

2.47M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.15B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Adams Street Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Adams Street Partners LLC with notifications on news.